Niemann-Pick Type A PerlQuest
“Perlara’s unique drug discovery platform and business model is a perfect fit for advancing our efforts in discovering existing compounds that can be repurposed, and new novel compounds that can be optimized for treating Niemann-Pick Type A,”
— Steven Laffoon, Co-Founder and President of Wylder Nation Foundation
We got off to a running start in January, and we’re looking forward to seeing initial data in the second quarter. We’ll keep you posted about progress as we move along.
Launch your own PerlQuest
Still have questions about PerlQuests?
Follow other PerlQuests
PerlQuest updates from our Blog
In December of 2016, Perlara partnered with Wylder Nation to initiate an NPA PerlQuest, a research and drug discovery program for Niemann Pick Type A disease. If you've been...
A few months ago, Taryn Sumabat blogged about development of a fly model of a Niemann-Pick Type A Disease. Here I’ll remind you of the progress she described, and update you...